Healthcare -
Biotechnology - NASDAQ - US
$ 61.53
0.457 %
$ 11.7 B
Market Cap
37.07
P/E
BMRN - LONG-TERM DEBT
Long-term Debt BMRN - BioMarin Pharmaceutical Inc.
593 M
LAST VALUE
-27.00%
2 YEAR CAGR
-6.51%
5 YEAR CAGR
-1.00%
10 YEAR CAGR